Literature DB >> 22270539

Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch block.

Darryl P Leong1, Ulas Höke, Victoria Delgado, Dominique Auger, Joep Thijssen, Lieselot van Erven, Jeroen J Bax, Martin J Schalij, Nina Ajmone Marsan.   

Abstract

AIMS: The aims of this study were: (i) to characterize consecutive cardiac resynchronization therapy (CRT) recipients with right bundle branch block (RBBB) in comparison with left bundle branch block (LBBB) and (ii) to identify independent predictors of long-term outcome among CRT recipients with RBBB. The presence of RBBB has been associated with poorer prognosis after CRT compared with LBBB; however, little is known about the differences in cardiac mechanics between RBBB and LBBB patients. Furthermore, predictors of favourable outcome after CRT in patients with RBBB have not been identified. METHODS AND
RESULTS: Five hundred and sixty-one consecutive CRT recipients (89 with RBBB and 472 with LBBB) underwent echocardiography before and 6 months after CRT to determine left ventricular (LV) size and function, and interventricular and LV dyssynchrony (as measured by tissue Doppler imaging). Long-term follow-up to identify a composite endpoint of all-cause mortality or heart failure hospitalization was available. Right bundle branch block patients exhibited a higher prevalence of male gender, ischaemic heart disease, atrial fibrillation, and lower exercise capacity when compared with LBBB patients, despite smaller LV volumes. In addition, the extent of both interventricular and LV dyssynchrony was less in RBBB patients. Six months after CRT, RBBB patients also showed limited LV reverse remodelling. At long-term follow-up, LV dyssynchrony and mitral regurgitation were identified as independent predictors of all-cause mortality or heart failure hospitalization among RBBB patients.
CONCLUSION: Left ventricular dyssynchrony may be an important determinant of outcome following CRT in patients with RBBB and may help in the selection of CRT candidates.

Entities:  

Mesh:

Year:  2012        PMID: 22270539     DOI: 10.1093/eurheartj/ehr470

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

Review 1.  Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns?

Authors:  Mark N Belkin; Gaurav A Upadhyay
Journal:  Curr Cardiol Rep       Date:  2017-10-24       Impact factor: 2.931

2.  Improvement in quality of life with sacubitril/ /valsartan in cardiac resynchronization non-responders: The RESINA (RESynchronization plus an Inhibitor of Neprilysin/Angiotensin) registry.

Authors:  José Manuel Rubio Campal; Hugo Del Castillo; Belén Arroyo Rivera; Carmen de Juan Bitriá; Mikel Taibo Urquia; Pepa Sánchez Borque; Ángel Miracle Blanco; Loreto Bravo Calero; David Martí Sánchez; José Tuñón Fernández
Journal:  Cardiol J       Date:  2021-02-26       Impact factor: 2.737

3.  The role of electrocardiography in the elaboration of a new paradigm in cardiac resynchronization therapy for patients with nonspecific intraventricular conduction disturbance.

Authors:  András Vereckei; Gábor Katona; Zsuzsanna Szelényi; Gábor Szénási; Bálint Kozman; István Karádi
Journal:  J Geriatr Cardiol       Date:  2016-02       Impact factor: 3.327

4.  Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study.

Authors:  V A Kuznetsov; A M Soldatova; J D Kasprzak; D V Krinochkin; N N Melnikov
Journal:  Cardiovasc Ultrasound       Date:  2018-10-02       Impact factor: 2.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.